06.03.2020 capsensixx AG  DE000A2G9M17

DGAP-Adhoc: capsensixx AG: leap in earnings in the 4th quarter of 2019 and a positive full year 2019


 

DGAP-Ad-hoc: capsensixx AG / Key word(s): Preliminary Results/Annual Results
capsensixx AG: leap in earnings in the 4th quarter of 2019 and a positive full year 2019

06-March-2020 / 08:09 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


capsensixx with leap in earnings in the 4th quarter of 2019 and a positive full year

- EBITDA in the 4th quarter of 2019 rises to EUR 4.3 million (PY: EUR 1.4 million)

- EBITDA in the full year 2019 rises to EUR 9.2 million (PY: 7,8 Mio. Euro)

- Group companies Axxion and Oaklet can fully leverage their strength

Frankfurt am Main, 6 March 2020 - capsensixx AG (ISIN DE000A2G9M17), a leading provider of Financial Administration as a Service, has closed fiscal 2019 with a strong 4th quarter and recorded an altogether positive fiscal year. The strong year-end quarter underlines the operational capacity of the companies Axxion and Oaklet and hence of the capsensixx group as a whole after the disposal and deconsolidation of loss-maker coraixx GmbH & Co. KGaA (coraixx).

The following 2018 and 2019 ratios are stated before the deduction of minority interests, unless there is a separate reference to a deviation. According to preliminary and still unaudited figures, the group EBITDA according to IFRS amounted during the 4th quarter of 2019 to EUR 4.3 million versus EUR 1.4 million during the prior-year period. The earnings after taxes and minority interests turned to EUR +2.4 million after EUR -2.3 million during the prior-year period. (Q4 2018 comparative figures adjusted downward by EUR 1.9 million, effect from the deconsolidation of coraixx). On a full-year basis the EBITDA of capsensixx amounted in 2019 to EUR 9.2 million after EUR 7.8 million in 2018. As far as the group EBITDA is concerned, Axxion (ca. 80%) and Oaklet (ca. 20%) made equally positive contributions. The group earnings after taxes and minority interests were during the full year 2019 with EUR 2.5 million again significantly above the negative prior-year value of EUR -0.6 million (Q4 2018 comparative figures adjusted downward by EUR 1.9 million, effect from the deconsolidation of coraixx). In this connection the losses accumulated during the previous quarters in a different group structure were completely recovered during the 4th quarter and an altogether positive result was achieved. The net commission revenues (sales revenues minus transitory third-party commission revenues) amounted to EUR 23 million and were likewise above the prior-year level of EUR 22 million.

The publication of the Annual Report 2019 will take place on 27 April 2020. Together with the final 2019 figures capsensixx AG will also publish the forecast for fiscal 2020.

About capsensixx

capsensixx manages, structures and executes financial products in various asset classes and product workflows in the financial sector for its customers (Financial Administration as a Service). The business model, which focuses on funds and alternative assets, is characterized by a high proportion of recurring income and profitable growth. The subsidiaries Axxion (capital management) and Oaklet (specialist for securitization and other financial services) have a very strong position on the German-speaking market in these two areas.

You can find more information at www.capsensixx.de

Contact:

Media Relations
edicto GmbH
Axel Mühlhaus/ Dr. Sönke Knop
Phone: +49(0)69 905505-52
E-mail: [email protected]


06-March-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: capsensixx AG
Bettinastraße 57-59
60325 Frankfurt
Germany
E-mail: [email protected]
Internet: www.capsensixx.de
ISIN: DE000A2G9M17
WKN: A2G9M1
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 991221

 
End of Announcement DGAP News Service

991221  06-March-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=991221&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 116,20 116,66 112,09 110,31 179,95 119,75 127,00
EBITDA1,2 8,17 7,86 10,12 8,13 9,24 10,29 11,00
EBITDA-Marge3 7,03 6,74 9,03 7,37 5,14 8,59
EBIT1,4 7,19 4,46 7,25 6,17 7,77 8,76 9,10
EBIT-Marge5 6,19 3,82 6,47 5,59 4,32 7,32 7,17
Jahresüberschuss1 4,98 2,34 5,08 4,65 6,25 6,12 6,40
Netto-Marge6 4,29 2,01 4,53 4,22 3,47 5,11 5,04
Cashflow1,7 5,95 5,81 0,74 6,08 7,70 8,91 0,00
Ergebnis je Aktie8 0,74 -0,25 0,70 0,66 0,94 0,92 0,98
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Capsensixx
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2G9M1 14,700 Halten 45,42
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
15,31 16,26 0,94 22,07
KBV KCV KUV EV/EBITDA
3,05 5,10 0,38 2,62
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 26.06.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.05.20234 30.08.2024 20.11.2023 29.04.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,89% -5,05% -10,91% -2,65%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu capsensixx AG  ISIN: DE000A2G9M17 können Sie bei EQS abrufen


Finanzdienstleistungen , A2G9M1 , CPX , XETR:CPX